First CRISPR trial in humans will attempt to battle lung cancer

7/26/2016

This article discusses the first human trial involving the gene-editing technology known as CRISPR-Cas9. The trial, conducted in China, aimed to test the effectiveness of using CRISPR to edit the DNA of immune cells to target and eliminate cancer cells in lung cancer patients. The article explains the process and potential implications of CRISPR gene editing, highlighting both the excitement and ethical concerns surrounding this groundbreaking technology. The trial results, although preliminary, showed promise in terms of safety and potential efficacy. This trial marks an important milestone in the development and application of CRISPR technology in human medicine.

genetic mutations ꞏ medical research ꞏ crispr ꞏ genetic manipulation ꞏ gene-based therapies ꞏ gene therapy ꞏ genetic testing ꞏ genetic advancements ꞏ ethical implications ꞏ genetic disorders ꞏ gene sequencing ꞏ molecular biology ꞏ genetic revolution ꞏ biotechnology ꞏ precision medicine ꞏ cancer treatment ꞏ genetic diseases ꞏ personalized medicine ꞏ gene editing ꞏ genomic medicine ꞏ chinese research ꞏ clinical trials ꞏ genetic technology ꞏ experimental treatments ꞏ healthcare ꞏ scientific breakthrough ꞏ genetic medicine ꞏ therapeutic applications ꞏ genetics research ꞏ dna editing ꞏ genetic engineering ꞏ genetic modification ꞏ biomedical ethics